In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) was $14.51 for the day, down -1.23% from the previous closing price of $14.69. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 2.73 million shares were traded. SBRA stock price reached its highest trading level at $14.915 during the session, while it also had its lowest trading level at $14.435.
Ratios:
Our analysis of SBRA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.76. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.90.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on January 30, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On October 17, 2023, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $16.
Wells Fargo Upgraded its Underweight to Equal Weight on October 16, 2023, whereas the target price for the stock was revised from $13 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 01 ’23 when Costa Michael Lourenco bought 1,947 shares for $12.63 per share. The transaction valued at 24,591 led to the insider holds 183,218 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 3359006976 and an Enterprise Value of 5747746816. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 68.44, and their Forward P/E ratio for the next fiscal year is 22.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 9.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.07 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 8.839 whereas that against EBITDA is 14.592.
Stock Price History:
The Beta on a monthly basis for SBRA is 1.21, which has changed by 0.30720723 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $14.92, while it has fallen to a 52-week low of $10.10. The 50-Day Moving Average of the stock is 2.44%, while the 200-Day Moving Average is calculated to be 5.61%.
Shares Statistics:
SBRA traded an average of 1.99M shares per day over the past three months and 2172120 shares per day over the past ten days. A total of 231.27M shares are outstanding, with a floating share count of 227.80M. Insiders hold about 1.60% of the company’s shares, while institutions hold 93.82% stake in the company. Shares short for SBRA as of 1714435200 were 12954604 with a Short Ratio of 6.51, compared to 1711584000 on 11191143. Therefore, it implies a Short% of Shares Outstanding of 12954604 and a Short% of Float of 8.0699995.
Dividends & Splits
With its trailing 12-month dividend rate of 1.2, SBRA has a forward annual dividend rate of 1.20. Against a Trailing Annual Dividend Yield of 0.081688225The stock’s 5-year Average Dividend Yield is 9.05. The current Payout Ratio is 2030.46% for SBRA, which recently paid a dividend on 2024-02-12 with an ex-dividend date of 1715904000. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
Investors are keenly observing as 7.0 analysts analyze and rate the current performance of Sabra Healthcare REIT Inc (SBRA) in the stock market.On average, analysts expect EPS of $0.15 for the current quarter, with a high estimate of $0.15 and a low estimate of $0.14, while EPS last year was $0.09. The consensus estimate for the next quarter is $0.15, with high estimates of $0.16 and low estimates of $0.14.
Analysts are recommending an EPS of between $0.6 and $0.55 for the fiscal current year, implying an average EPS of $0.58. EPS for the following year is $0.65, with 7.0 analysts recommending between $0.7 and $0.58.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 10 analysts. It ranges from a high estimate of $169.02M to a low estimate of $155.7M. As of the current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $161.17MFor the next quarter, 10 analysts are estimating revenue of $164.28M. There is a high estimate of $172.87M for the next quarter, whereas the lowest estimate is $157.4M.
A total of 10 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $684.21M, while the lowest revenue estimate was $626.3M, resulting in an average revenue estimate of $652.85M. In the same quarter a year ago, actual revenue was $647.52MBased on 10 analysts’ estimates, the company’s revenue will be $686.4M in the next fiscal year. The high estimate is $741.44M and the low estimate is $650.9M.
